1.
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Heier Jeffrey S, Antoszyk Andrew N, Pavan Peter Reed, Leff Steven R, Rosenfeld Philip J, Ciulla Thomas A et al.
OphthalmologyApr 2006253 citationsRandomized Controlled Trial
Ranibizumab injections for neovascular AMD safely improved vision and reduced leakage, demonstrating its efficacy for this sight-threatening condition.